United Kingdom· GB-APID-42728111000001106
Velsipity 2mg tablets
A etrasimod product containing etrasimod, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Etrasimod is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AE05 (etrasimod), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Etrasimod · ATC L04AE05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of etrasimod costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Etrasimod · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$35.97
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Etrasimod
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AE05
- ATC class
- Etrasimod
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5415062109212
- gtin5415062109861
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etrasimod in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaVELSIPITYPFIZER CANADA ULC
- SwitzerlandVelsipity 2 mg, FilmtablettenPfizer AG
- SpainVELSIPITY 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPfizer Europe Ma Eeig
- NorwayVelsipityPfizer Europe MA EEIG
- PolandVelsipityPfizer Europe MA EEIG
- SwedenVelsipity 2 mg Filmdragerad tablettPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Velsipity
- Liechtenstein · Velsipity
- Norway · Velsipity
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5cde5132-b5a2-48cf-aa15-99e13ccdfcc5 GET /v1/drugs/5cde5132-b5a2-48cf-aa15-99e13ccdfcc5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42728111000001106",
"desc": "Velsipity 2mg tablets (Pfizer Ltd)",
"form": "Oral tablet",
"vpid": "42741111000001100",
"source": "dmd",
"vtm_id": "42731711000001100",
"strength": "2 mg",
"substance": "Etrasimod",
"ingredient": "Etrasimod arginine",
"supplier_code": "2082201000001106"
}See everything about etrasimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.